Latest Breaking News On - Prnewswire lyra therapeutics inc - Page 1 : comparemela.com

Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ Lyra Therapeutics, Inc. (Nasdaq: LYRA) (the Company, Lyra or Lyra Therapeutics), a clinical-stage therapeutics company leveraging its.

Kathryn morrisEllen cavaleriWhile the companyYates networkExchange commissionPrnewswire lyra therapeutics incLyra therapeutics incCompany quarterly report on formLyra therapeuticsAward planSenior vice presidentInvestor relationsNasdaq listing rulePrivate securities litigation reform actQuarterly report

LYRA THERAPEUTICS announces additional data presentations FROM PHASE 2 LANTERN STUDY at the americal rhinologic society annual meeting

LYRA THERAPEUTICS announces additional data presentations FROM PHASE 2 LANTERN STUDY at the americal rhinologic society annual meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRichard niemanExchange commissionWhile the companyCompany or lyraUniversity of north carolina at chapel hillDepartment of otolaryngologyKathryn morristhe yates networkPrnewswire lyra therapeutics incLyra therapeutics incCompany quarterly report on formAmerican rhinologic societyAnnual meetingNeck surgeryNorth carolinaChapel hill

Lyra Therapeutics to Present at the H C Wainwright AnnualGlobal Investment Conference 2022

/PRNewswire/ Lyra Therapeutics, Inc. (Nasdaq: LYRA) (the Company or Lyra), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform.

Kathryn morrisMaria palasisSecurities exchange commissionLotte new york palace hotelWhile the companyYates networkCompany or lyraPrnewswire lyra therapeutics incLyra therapeutics incCompany quarterly report on formAnnual global investment conferenceChief executive officerInvestor relationsPrivate securities litigation reform actQuarterly reportLyra therapeutics

Lyra Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

/PRNewswire/ Lyra Therapeutics, Inc. (Nasdaq: LYRA)("Lyra" or the "Company"), a clinical-stage therapeutics company leveraging its proprietary XTreo™.

United statesMaria palasisRichard niemanBristol myers squibbPrnewswire lyra therapeutics incNantahala capital managementLyra therapeutics incAmerican rhinologic societyChief medicalChief executive officerChief medical officerMedical headGlobal medical officerAsia pacific medicalPerceptive advisorsNorth bridge venture partners

Lyra Therapeutics to Present at the William Blair Biotech Focus Conference 2022

/PRNewswire/ Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise,.

Kathryn morrisMaria palasisYates networkPrnewswire lyra therapeutics incLyra therapeutics incWilliam blair biotech focus conferenceChief executive officerRegis new yorkInvestor relationsPrivate securities litigation reform actQuarterly reportLyra therapeutics